InMed Pharmaceuticals Inc. (INM)
NASDAQ · Healthcare
InMed Pharmaceuticals Inc. Operating Income 2021–2025
InMed Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2021 to 2023. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- InMed Pharmaceuticals Inc. operating income for the quarter ending September 30, 2023 was -2.5 M, a 27.73% decrease year-over-year.
- InMed Pharmaceuticals Inc. operating income for the twelve months ending September 30, 2023 was -10.1 M, a 22.57% decrease year-over-year.
- InMed Pharmaceuticals Inc. annual operating income for 2023 was -7.9 M, a 57.27% decrease from 2022.
- InMed Pharmaceuticals Inc. annual operating income for 2022 was -18.6 M, a 82.30% increase from 2021.
- InMed Pharmaceuticals Inc. annual operating income for 2021 was -10.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
InMed Pharmaceuticals Inc. Operating Income — FAQ
InMed Pharmaceuticals Inc. (INM) operating income over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INM's operating income history?
The chart and table above show InMed Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.